The motor activity of the GASTROINTESTINAL TRACT.
The evacuation of food from the stomach into the duodenum.
Passage of food (sometimes in the form of a test meal) through the gastrointestinal tract as measured in minutes or hours. The rate of passage through the intestine is an indicator of small bowel function.
A peptide of about 22-amino acids isolated from the DUODENUM. At low pH it inhibits gastric motor activity, whereas at high pH it has a stimulating effect.
Two ganglionated neural plexuses in the gut wall which form one of the three major divisions of the autonomic nervous system. The enteric nervous system innervates the gastrointestinal tract, the pancreas, and the gallbladder. It contains sensory neurons, interneurons, and motor neurons. Thus the circuitry can autonomously sense the tension and the chemical environment in the gut and regulate blood vessel tone, motility, secretions, and fluid transport. The system is itself governed by the central nervous system and receives both parasympathetic and sympathetic innervation. (From Kandel, Schwartz, and Jessel, Principles of Neural Science, 3d ed, p766)
A condition caused by the lack of intestinal PERISTALSIS or INTESTINAL MOTILITY without any mechanical obstruction. This interference of the flow of INTESTINAL CONTENTS often leads to INTESTINAL OBSTRUCTION. Ileus may be classified into postoperative, inflammatory, metabolic, neurogenic, and drug-induced.
An ethical system which emphasizes human values and the personal worth of each individual, as well as concern for the dignity and freedom of humankind.
Nerve cells where transmission is mediated by NITRIC OXIDE.
A plant genus of the family FABACEAE. SENNA EXTRACT is obtained from members of this genus. Members contain ANTHRAQUINONES and have been an ingredient in laxatives (CATHARTICS). Many species of the CASSIA genus have been reclassified into this genus. This bush should not be confused with the Cassia tree (CINNAMOMUM).
A plant genus of the family RUTACEAE. Members contain murrayanine, koenine, isomahanine, kwangsine, siamenol, murrayafoline A, murrayaquinone A and other cytotoxic carbazolequinones.
A condition caused by one or more episodes of DEEP VEIN THROMBOSIS, usually the blood clots are lodged in the legs. Clinical features include EDEMA; PAIN; aching; heaviness; and MUSCLE CRAMP in the leg. When severe leg swelling leads to skin breakdown, it is called venous STASIS ULCER.
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion.
A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.
A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
A type of ILEUS, a functional not mechanical obstruction of the INTESTINES. This syndrome is caused by a large number of disorders involving the smooth muscles (MUSCLE, SMOOTH) or the NERVOUS SYSTEM.
Movement characteristics of SPERMATOZOA in a fresh specimen. It is measured as the percentage of sperms that are moving, and as the percentage of sperms with productive flagellar motion such as rapid, linear, and forward progression.
HORMONES secreted by the gastrointestinal mucosa that affect the timing or the quality of secretion of digestive enzymes, and regulate the motor activity of the digestive system organs.
Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
c-Kit positive cells related to SMOOTH MUSCLE CELLS that are intercalated between the autonomic nerves and the effector smooth muscle cells of the GASTROINTESTINAL TRACT. Different phenotypic classes play roles as pacemakers, mediators of neural inputs, and mechanosensors.
An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM.
The shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers.
Generally refers to the digestive structures stretching from the MOUTH to ANUS, but does not include the accessory glandular organs (LIVER; BILIARY TRACT; PANCREAS).
Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.
A dopamine D2 antagonist that is used as an antiemetic.
The occupational discipline of the traditional Chinese methods of ACUPUNCTURE THERAPY for treating disease by inserting needles along specific pathways or meridians.
Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed)
Chronic or recurrent colonic disorders without an identifiable structural or biochemical explanation. The widely recognized IRRITABLE BOWEL SYNDROME falls into this category.
A movement, caused by sequential muscle contraction, that pushes the contents of the intestines or other tubular organs in one direction.
Properties and processes of the DIGESTIVE SYSTEM as a whole or of any of its parts.
Agents that are used to stimulate evacuation of the bowels.
Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT4 RECEPTORS.
One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.
The region between the sharp indentation at the lower third of the STOMACH (incisura angularis) and the junction of the PYLORUS with the DUODENUM. Pyloric antral glands contain mucus-secreting cells and gastrin-secreting endocrine cells (G CELLS).
The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM.
Measurement of the pressure or tension of liquids or gases with a manometer.
Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections.
The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
The normal process of elimination of fecal material from the RECTUM.
One of two ganglionated neural networks which together form the ENTERIC NERVOUS SYSTEM. The myenteric (Auerbach's) plexus is located between the longitudinal and circular muscle layers of the gut. Its neurons project to the circular muscle, to other myenteric ganglia, to submucosal ganglia, or directly to the epithelium, and play an important role in regulating and patterning gut motility. (From FASEB J 1989;3:127-38)
A group of organs stretching from the MOUTH to the ANUS, serving to breakdown foods, assimilate nutrients, and eliminate waste. In humans, the digestive system includes the GASTROINTESTINAL TRACT and the accessory glands (LIVER; BILIARY TRACT; PANCREAS).
A plastic surgical operation on the nose, either reconstructive, restorative, or cosmetic. (Dorland, 28th ed)
A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.
A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.
A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
Viscous, nauseating oil obtained from the shrub Croton tiglium (Euphorbaceae). It is a vesicant and skin irritant used as pharmacologic standard for skin inflammation and allergy and causes skin cancer. It was formerly used as an emetic and cathartic with frequent mortality.
An enzyme that catalyzes the transfer of galactose from UDP-galactose to a specific glycoprotein receptor, 2-acetamido-2-deoxy-D-glucosyl-glycopeptide, during glycopeptide synthesis. EC
A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety.
The consumption of edible substances.
The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum.
The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL.
Abstaining from all food.
A storage reservoir for BILE secretion. Gallbladder allows the delivery of bile acids at a high concentration and in a controlled manner, via the CYSTIC DUCT to the DUODENUM, for degradation of dietary lipid.
A CALCIUM-dependent, constitutively-expressed form of nitric oxide synthase found primarily in NERVE TISSUE.
The 10th cranial nerve. The vagus is a mixed nerve which contains somatic afferents (from skin in back of the ear and the external auditory meatus), visceral afferents (from the pharynx, larynx, thorax, and abdomen), parasympathetic efferents (to the thorax and abdomen), and efferents to striated muscle (of the larynx and pharynx).
A family of hexahydropyridines.
Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard.
The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell.
A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.
The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE.
A type of stress exerted uniformly in all directions. Its measure is the force exerted per unit area. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine.
An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator.
A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.
The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)
A whiplike motility appendage present on the surface cells. Prokaryote flagella are composed of a protein called FLAGELLIN. Bacteria can have a single flagellum, a tuft at one pole, or multiple flagella covering the entire surface. In eukaryotes, flagella are threadlike protoplasmic extensions used to propel flagellates and sperm. Flagella have the same basic structure as CILIA but are longer in proportion to the cell bearing them and present in much smaller numbers. (From King & Stansfield, A Dictionary of Genetics, 4th ed)
The relationship between the dose of an administered drug and the response of the organism to the drug.
Mature male germ cells derived from SPERMATIDS. As spermatids move toward the lumen of the SEMINIFEROUS TUBULES, they undergo extensive structural changes including the loss of cytoplasm, condensation of CHROMATIN into the SPERM HEAD, formation of the ACROSOME cap, the SPERM MIDPIECE and the SPERM TAIL that provides motility.
Elements of limited time intervals, contributing to particular results or situations.
Disorders affecting the motor function of the UPPER ESOPHAGEAL SPHINCTER; LOWER ESOPHAGEAL SPHINCTER; the ESOPHAGUS body, or a combination of these parts. The failure of the sphincters to maintain a tonic pressure may result in gastric reflux of food and acid into the esophagus (GASTROESOPHAGEAL REFLUX). Other disorders include hypermotility (spastic disorders) and markedly increased amplitude in contraction (nutcracker esophagus).
A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
The act, process, or result of passing from one place or position to another. It differs from LOCOMOTION in that locomotion is restricted to the passing of the whole body from one place to another, while movement encompasses both locomotion but also a change of the position of the whole body or any of its parts. Movement may be used with reference to humans, vertebrate and invertebrate animals, and microorganisms. Differentiate also from MOTOR ACTIVITY, movement associated with behavior.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.

Gallstones: an intestinal disease? (1/2083)

Current evidence suggests that impaired intestinal motility may facilitate gallstone formation by influencing biliary deoxycholate levels or by modulating interdigestive gall bladder motility (fig 2), although a primary intestinal defect in gallstone pathogenesis has not yet been demonstrated. In the cold war period, most interesting events, from a political point of view, occurred at the border between capitalist and communist systems, near the iron curtain. Similarly, the gall bladder and biliary tract can be viewed as the border between liver and intestinal tract, where many interesting things occur with profound impact on both systems. Combined efforts by researchers in the field of hepatology and gastrointestinal motility should brake down the Berlin wall of ignorance of one of the most common diseases in the Western world.  (+info)

Pharmacological studies on root bark of mulberry tree (Morus alba L.) (2/2083)

Pharmacological studies were done on the root bark of mulberry tree and pharmacological effects were compared with the clinical effects of "Sohakuhi" in Chinese medicine. n-Butanol- and water-soluble fractions of mulberry root had similar effects except for those on the cadiovascular system. Both fractions showed cathartic, analgesic, diuretic, antitussive, antiedema, sedative, anticonvulsant, and hypotensive actions in mice, rats, guinea pigs and dogs. There appears to be a correlation between the experimental pharmacological results and the clinical applications of mulberry root found in the literature on Chinese medicine.  (+info)

Retarded growth and deficits in the enteric and parasympathetic nervous system in mice lacking GFR alpha2, a functional neurturin receptor. (3/2083)

Glial cell line-derived neurotrophic factor (GDNF) and a related protein, neurturin (NTN), require a GPI-linked coreceptor, either GFR alpha1 or GFR alpha2, for signaling via the transmembrane Ret tyrosine kinase. We show that mice lacking functional GFR alpha2 coreceptor (Gfra2-/-) are viable and fertile but have dry eyes and grow poorly after weaning, presumably due to malnutrition. While the sympathetic innervation appeared normal, the parasympathetic cholinergic innervation was almost absent in the lacrimal and salivary glands and severely reduced in the small bowel. Neurite outgrowth and trophic effects of NTN at low concentrations were lacking in Gfra2-/- trigeminal neurons in vitro, whereas responses to GDNF were similar between the genotypes. Thus, GFR alpha2 is a physiological NTN receptor, essential for the development of specific postganglionic parasympathetic neurons.  (+info)

Effects of duodenal distension on antropyloroduodenal pressures and perception are modified by hyperglycemia. (4/2083)

Marked hyperglycemia (blood glucose approximately 15 mmol/l) affects gastrointestinal motor function and modulates the perception of gastrointestinal sensations. The aims of this study were to evaluate the effects of mild hyperglycemia on the perception of, and motor responses to, duodenal distension. Paired studies were done in nine healthy volunteers, during euglycemia ( approximately 4 mmol/l) and mild hyperglycemia ( approximately 10 mmol/l), in randomized order, using a crossover design. Antropyloroduodenal pressures were recorded with a manometric, sleeve-side hole assembly, and proximal duodenal distensions were performed with a flaccid bag. Intrabag volumes were increased at 4-ml increments from 12 to 48 ml, each distension lasting for 2.5 min and separated by 10 min. Perception of the distensions and sensations of fullness, nausea, and hunger were evaluated. Perceptions of distension (P < 0.001) and fullness (P < 0.05) were greater and hunger less (P < 0.001) during hyperglycemia compared with euglycemia. Proximal duodenal distension stimulated pyloric tone (P < 0.01), isolated pyloric pressure waves (P < 0.01), and duodenal pressure waves (P < 0.01). Compared with euglycemia, hyperglycemia was associated with increases in pyloric tone (P < 0.001), the frequency (P < 0.05) and amplitude (P < 0.01) of isolated pyloric pressure waves, and the frequency of duodenal pressure waves (P < 0.001) in response to duodenal distension. Duodenal compliance was less (P < 0.05) during hyperglycemia compared with euglycemia, but this did not account for the effects of hyperglycemia on perception. We conclude that both the perception of, and stimulation of pyloric and duodenal pressures by, duodenal distension are increased by mild hyperglycemia. These observations are consistent with the concept that the blood glucose concentration plays a role in the regulation of gastrointestinal motility and sensation.  (+info)

Regional effects of cholecystokinin octapeptide on colonic phasic and tonic motility in healthy humans. (5/2083)

The aim of this study was to assess in nine healthy subjects the effects of CCK octapeptide (CCK-8) on colonic tonic activity, measured by a barostat, and phasic activity, measured by manometry. On 2 consecutive days, recordings were performed in the unprepared proximal and distal colons during intravenous infusion of saline and CCK-8 at 5, 20, and 40 ng. kg-1. h-1. In the proximal colon CCK-8 induced, at the 20 and 40 ng. kg-1. h-1 doses, a tonic relaxation with an increase in barostat bag volume to 156 +/- 25 and 157 +/- 19% of basal (P < 0.01) and a decrease in phasic activity to 72 +/- 7 and 76 +/- 7% of basal (P < 0.01). In the distal colon, CCK-8 induced, at the 20 and 40 ng. kg-1. h-1 doses, a tonic relaxation (increase in intrabag volume to 133 +/- 12 and 149 +/- 15%, respectively; P < 0.01), whereas phasic activity increased (128 +/- 8 and 132 +/- 6%, respectively; P < 0.01). Effects of CCK-8 on tonic and phasic activities are different according to the colonic segment. Because meals induce colonic tonic contraction, our results suggest that CCK, as a hormone, is not an important mediator of the response of the colon to feeding in humans.  (+info)

5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats. (6/2083)

We previously demonstrated a change in the receptors mediating 5-hydroxytryptamine (5-HT)-induced contraction in arteries of deoxycorticosterone acetate (DOCA)-salt-hypertensive rats. Specifically, contraction to 5-HT is mediated primarily by 5-HT2A receptors in arteries from normotensive sham rats and by both 5-HT2A and 5-HT2B receptors in arteries from hypertensive rats. We hypothesized that the 5-HT2B receptor may play a role in maintaining the high blood pressure of DOCA-salt-hypertensive rats, and herein we provide data connecting in vitro and in vivo findings. The endothelium-denuded isolated superior mesenteric artery of DOCA-salt rats displayed a marked increase in maximum contraction to the newly available 5-HT2B-receptor agonist BW-723C86 compared with that of arteries from sham rats, confirming that the 5-HT2B receptor plays a greater role in 5-HT-induced contraction in arteries from DOCA-salt rats. In chronically instrumented rats, the 5-HT2B-receptor antagonist LY-272015 (0.3, 1.0, and 3.0 mg/kg iv at 30-min intervals) was given cumulatively 1 time/wk during 4 wk of continued DOCA-salt treatment. LY-272015 did not reduce blood pressure of the sham-treated rats at any time or dose. However, LY-272015 (1.0 and 3. 0 mg/kg) significantly reduced mean blood pressure in a subgroup of week 3 (-20 mmHg) and week 4 DOCA-salt (-40 mmHg) rats that had extremely high blood pressure (mean arterial blood pressure approximately 200 mmHg). Blockade of 5-HT2B receptors by in vivo administration of LY-272015 (3.0 mg/kg) was verified by observing reduced 5-HT-induced contraction in rat stomach fundus, the tissue from which the 5-HT2B receptor was originally cloned. These data support the novel hypothesis that 5-HT2B-receptor expression is induced during the development of DOCA-salt hypertension and contributes to the maintenance of severe blood pressure elevations.  (+info)

Erythromycin enhances early postoperative contractility of the denervated whole stomach as an esophageal substitute. (7/2083)

OBJECTIVE: To determine whether early postoperative administration of erythromycin accelerates the spontaneous motor recovery process after elevation of the denervated whole stomach up to the neck. SUMMARY BACKGROUND DATA: Spontaneous motor recovery after gastric denervation is a slow process that progressively takes place over years. METHODS: Erythromycin was administered as follows: continuous intravenous (i.v.) perfusion until postoperative day 10 in ten whole stomach (WS) patients at a dose of either 1 g (n = 5) or 2 g (n = 5) per day; oral intake at a dose of 1 g/day during 1.5 to 8 months after surgery in 11 WS patients, followed in 7 of them by discontinuation of the drug during 2 to 4 weeks. Gastric motility was assessed with intraluminal perfused catheters in these 21 patients, in 23 WS patients not receiving erythromycin, and in 11 healthy volunteers. A motility index was established by dividing the sum of the areas under the curves of >9 mmHg contractions by the time of recording. RESULTS: The motility index after IV or oral administration of erythromycin at and after surgery was significantly higher than that without erythromycin (i.v., 1 g: p = 0.0090; i.v., 2 g: p = 0.0090; oral, 1 g: p = 0.0017). It was similar to that in healthy volunteers (i.v., 1 g: p = 0.2818; oral, 1 g: p = 0.7179) and to that in WS patients with >3 years of follow-up who never received erythromycin (i.v., 1 g: p = 0.2206; oral, 1 g: p = 0.8326). The motility index after discontinuation of the drug was similar or superior to that recorded under medication in four patients who did not experience any modification of their alimentary comfort, whereas it dropped dramatically parallel to deterioration of the alimentary comfort in three patients. CONCLUSIONS: Early postoperative contractility of the denervated whole stomach pulled up to the neck under either i.v. or oral erythromycin is similar to that recovered spontaneously beyond 3 years of follow-up. In some patients, this booster effect persists after discontinuation of the drug.  (+info)

The effect of motilin on the regulation mechanism of intestinal motility in conscious horses. (8/2083)

Laparotomy was performed on seven thoroughbreds to attach a force transducer to the proximal jejunum, distal jejunum, and ileum, as well as to the serous membrane of the cecum. Following observation of intestinal motility in conscious horses, they were intravenously injected with motilin (0.6 microgram/kg) to examine its effect on intestinal motility. Strong contractions peculiar to horses were observed in small intestine. Further, motilin caused strong contractions in the proximal jejunum. The results suggested the involvement of motilin in the regulation mechanism of intestinal motility.  (+info)

The word 'ileus' comes from the Greek word 'íleos', which means 'intestine'.

The exact cause of PTS is not fully understood, but it is thought to be related to inflammation, damage to the vein wall, and abnormalities in blood flow. Risk factors for developing PTS include previous DVT, long-term immobility, obesity, and smoking.

Symptoms of PTS can vary in severity and may include:

* Pain or tenderness in the affected limb
* Swelling in the affected limb
* Skin discoloration (redness or bluing) in the affected limb
* Limited mobility or stiffness in the affected limb
* Cramping or aching pain in the affected limb
* Fatigue or weakness in the affected limb

PTS can be diagnosed through a physical examination, medical history, and imaging tests such as ultrasound or venography. Treatment for PTS typically involves anticoagulation therapy to prevent further clotting, compression stockings to reduce swelling, and pain management with medication or other interventions. In severe cases, surgery may be necessary to remove the clot or repair damaged veins.

Prevention of PTS is key, and this includes early diagnosis and treatment of DVT, avoiding long-term immobility, maintaining a healthy weight, and avoiding smoking. Managing underlying conditions such as cancer, autoimmune disorders, or inflammatory diseases can also help reduce the risk of developing PTS.

Overall, Postthrombotic Syndrome is a common complication of DVT that can have a significant impact on quality of life. Prompt diagnosis and appropriate treatment are essential to manage symptoms and prevent long-term morbidity.

The condition can be caused by various factors, including:

1. Neurological disorders: Conditions such as Parkinson's disease, multiple sclerosis, and spinal cord injuries can damage the nerves that control intestinal movement, leading to pseudo-obstruction.
2. Medications: Certain medications, such as anticholinergics and opioids, can slow down intestinal motility and cause pseudo-obstruction.
3. Inflammatory bowel disease: Inflammatory conditions such as Crohn's disease and ulcerative colitis can damage the muscles in the intestinal wall, leading to pseudo-obstruction.
4. Surgery: Intestinal surgery can sometimes result in adhesions or scar tissue that can cause pseudo-obstruction.
5. Infections: Infections such as appendicitis and diverticulitis can inflame the intestines and disrupt their function, leading to pseudo-obstruction.
6. Cancer: Cancer of the intestine or surrounding tissues can obstruct the flow of food through the intestines and cause pseudo-obstruction.

Treatment for intestinal pseudo-obstruction typically involves supportive care, such as fluids, electrolytes, and oxygen, as well as medications to manage symptoms. In severe cases, surgery may be necessary to remove any blockages or adhesions that are causing the condition.

Types of Gastrointestinal Diseases:

1. Irritable Bowel Syndrome (IBS): A common condition characterized by abdominal pain, bloating, and changes in bowel movements.
2. Inflammatory Bowel Disease (IBD): A group of chronic conditions that cause inflammation in the digestive tract, including Crohn's disease and ulcerative colitis.
3. Gastroesophageal Reflux Disease (GERD): A condition in which stomach acid flows back into the esophagus, causing heartburn and other symptoms.
4. Peptic Ulcer Disease: A condition characterized by ulcers in the lining of the stomach or duodenum.
5. Diverticulitis: A condition in which small pouches form in the wall of the colon and become inflamed.
6. Gastritis: Inflammation of the stomach lining, often caused by infection or excessive alcohol consumption.
7. Esophagitis: Inflammation of the esophagus, often caused by acid reflux or infection.
8. Rectal Bleeding: Hemorrhage from the rectum, which can be a symptom of various conditions such as hemorrhoids, anal fissures, or inflammatory bowel disease.
9. Functional Dyspepsia: A condition characterized by recurring symptoms of epigastric pain, bloating, nausea, and belching.
10. Celiac Disease: An autoimmune disorder that causes the immune system to react to gluten, leading to inflammation and damage in the small intestine.

Causes of Gastrointestinal Diseases:

1. Infection: Viral, bacterial, or parasitic infections can cause gastrointestinal diseases.
2. Autoimmune Disorders: Conditions such as Crohn's disease and ulcerative colitis occur when the immune system mistakenly attacks healthy tissue in the GI tract.
3. Diet: Consuming a diet high in processed foods, sugar, and unhealthy fats can contribute to gastrointestinal diseases.
4. Genetics: Certain genetic factors can increase the risk of developing certain gastrointestinal diseases.
5. Lifestyle Factors: Smoking, excessive alcohol consumption, stress, and lack of physical activity can all contribute to gastrointestinal diseases.
6. Radiation Therapy: Exposure to radiation therapy can damage the GI tract and increase the risk of developing certain gastrointestinal diseases.
7. Medications: Certain medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids can cause gastrointestinal side effects.

Functional colonic diseases include:

1. Irritable Bowel Syndrome (IBS): A common condition characterized by recurring abdominal pain, bloating, and changes in bowel habits (diarrhea or constipation).
2. Functional dyspepsia: A condition characterized by recurring symptoms of epigastric pain, discomfort, bloating, and nausea, without any identifiable organic cause.
3. Functional constipation: A condition characterized by infrequent bowel movements, hard or difficult-to-pass stools, and sensation of incomplete evacuation.
4. Functional diarrhea: A condition characterized by frequent, loose, and watery bowel movements.
5. Functional abdominal pain: Recurring abdominal pain without any identifiable organic cause.

The exact causes of functional colonic diseases are not fully understood, but they are thought to be related to abnormalities in the functioning of the enteric nervous system, immune system, and gut microbiome. These conditions are often associated with stress, dietary factors, and other lifestyle factors.

The diagnosis of functional colonic diseases is based on a combination of clinical symptoms, physical examination, and laboratory tests (such as stool studies and gastrointestinal imaging). Treatment typically involves lifestyle modifications (such as dietary changes and stress management) and medications (such as antispasmodics, antidepressants, and laxatives) to manage symptoms and improve quality of life.

The definition of constipation varies depending on the source, but it is generally defined as having fewer than three bowel movements per week, or as experiencing difficulty passing stools for more than half of the time during a two-week period. In addition, some people may experience "functional constipation," which means that they have normal bowel habits but still experience symptoms such as bloating and discomfort.

There are several factors that can contribute to constipation, including:

* Poor diet and dehydration: A diet low in fiber and high in processed foods can lead to constipation, as can not drinking enough water.
* Lack of physical activity: Sedentary lifestyles can contribute to constipation by slowing down the digestive process.
* Medical conditions: Certain medical conditions, such as irritable bowel syndrome (IBS), thyroid disorders, and diabetes, can increase the risk of constipation.
* Medications: Some medications, such as painkillers and antidepressants, can cause constipation as a side effect.
* Hormonal changes: Changes in hormone levels during pregnancy, menopause, or other life events can lead to constipation.

Treatment for constipation depends on the underlying cause and may include dietary changes, lifestyle modifications, and medication. In severe cases, surgery may be necessary. It is important to seek medical advice if symptoms persist or worsen over time, as untreated constipation can lead to complications such as bowel obstruction, hemorrhoids, and fecal incontinence.

There are several subtypes of IBS, including:

* IBS-C (constipation-predominant)
* IBS-D (diarrhea-predominant)
* IBS-M (mixed)

The symptoms of IBS can vary in severity and frequency from person to person, and may include:

* Abdominal pain or cramping
* Bloating
* Gas
* Diarrhea or constipation
* Mucus in the stool
* Feeling of incomplete evacuation after bowel movements

There is no cure for IBS, but symptoms can be managed with dietary changes, stress management techniques, and medications such as fiber supplements, antispasmodics, and antidepressants. It is important to seek medical advice if symptoms persist or worsen over time, as IBS can have a significant impact on quality of life and may be associated with other conditions such as anxiety or depression.

There are several types of diarrhea, including:

1. Acute diarrhea: This type of diarrhea is short-term and usually resolves on its own within a few days. It can be caused by a viral or bacterial infection, food poisoning, or medication side effects.
2. Chronic diarrhea: This type of diarrhea persists for more than 4 weeks and can be caused by a variety of conditions, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), or celiac disease.
3. Diarrhea-predominant IBS: This type of diarrhea is characterized by frequent, loose stools and abdominal pain or discomfort. It can be caused by a variety of factors, including stress, hormonal changes, and certain foods.
4. Infectious diarrhea: This type of diarrhea is caused by a bacterial, viral, or parasitic infection and can be spread through contaminated food and water, close contact with an infected person, or by consuming contaminated food.

Symptoms of diarrhea may include:

* Frequent, loose, and watery stools
* Abdominal cramps and pain
* Bloating and gas
* Nausea and vomiting
* Fever and chills
* Headache
* Fatigue and weakness

Diagnosis of diarrhea is typically made through a physical examination, medical history, and laboratory tests to rule out other potential causes of the symptoms. Treatment for diarrhea depends on the underlying cause and may include antibiotics, anti-diarrheal medications, fluid replacement, and dietary changes. In severe cases, hospitalization may be necessary to monitor and treat any complications.

Prevention of diarrhea includes:

* Practicing good hygiene, such as washing hands frequently and thoroughly, especially after using the bathroom or before preparing food
* Avoiding close contact with people who are sick
* Properly storing and cooking food to prevent contamination
* Drinking safe water and avoiding contaminated water sources
* Avoiding raw or undercooked meat, poultry, and seafood
* Getting vaccinated against infections that can cause diarrhea

Complications of diarrhea can include:

* Dehydration: Diarrhea can lead to a loss of fluids and electrolytes, which can cause dehydration. Severe dehydration can be life-threatening and requires immediate medical attention.
* Electrolyte imbalance: Diarrhea can also cause an imbalance of electrolytes in the body, which can lead to serious complications.
* Inflammation of the intestines: Prolonged diarrhea can cause inflammation of the intestines, which can lead to abdominal pain and other complications.
* Infections: Diarrhea can be a symptom of an infection, such as a bacterial or viral infection. If left untreated, these infections can lead to serious complications.
* Malnutrition: Prolonged diarrhea can lead to malnutrition and weight loss, which can have long-term effects on health and development.

Treatment of diarrhea will depend on the underlying cause, but may include:

* Fluid replacement: Drinking plenty of fluids to prevent dehydration and replace lost electrolytes.
* Anti-diarrheal medications: Over-the-counter or prescription medications to slow down bowel movements and reduce diarrhea.
* Antibiotics: If the diarrhea is caused by a bacterial infection, antibiotics may be prescribed to treat the infection.
* Rest: Getting plenty of rest to allow the body to recover from the illness.
* Dietary changes: Avoiding certain foods or making dietary changes to help manage symptoms and prevent future episodes of diarrhea.

It is important to seek medical attention if you experience any of the following:

* Severe diarrhea that lasts for more than 3 days
* Diarrhea that is accompanied by fever, blood in the stool, or abdominal pain
* Diarrhea that is severe enough to cause dehydration or electrolyte imbalances
* Diarrhea that is not responding to treatment

Prevention of diarrhea includes:

* Good hand hygiene: Washing your hands frequently, especially after using the bathroom or before preparing food.
* Safe food handling: Cooking and storing food properly to prevent contamination.
* Avoiding close contact with people who are sick.
* Getting vaccinated against infections that can cause diarrhea, such as rotavirus.

Overall, while diarrhea can be uncomfortable and disruptive, it is usually a minor illness that can be treated at home with over-the-counter medications and plenty of fluids. However, if you experience severe or persistent diarrhea, it is important to seek medical attention to rule out any underlying conditions that may require more formal treatment.

There are several types of esophageal motility disorders, including:

1. Achalasia: A condition in which the lower esophageal sphincter (LES) does not relax properly, making it difficult for food to pass into the stomach.
2. Dysmotility: Abnormal movement of the muscles in the esophagus, which can cause slow or abnormal movement of food through the esophagus.
3. Hypercontractility: Excessive contraction of the muscles in the esophagus, which can cause spasms and difficulty swallowing.
4. Hypocontractility: Weak contraction of the muscles in the esophagus, which can cause regurgitation of food.

Esophageal motility disorders can be diagnosed using a variety of tests, including barium swallows, manometry, and high-resolution esophageal manometry. Treatment options vary depending on the specific disorder and its underlying causes, but may include medications to relax the LES or improve muscle function, or surgery to repair structural abnormalities in the esophagus.

1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.

2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.

3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.

4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.

5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.

6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.

7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.

8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.

9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.

10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.

Ginzburg, G. V.; Costoff, A. "3: Gastrointestinal Physiology. Gastrointestinal Motility". GI Smooth Muscle Electrophysiology: ... Motility of gastrointestinal tract (GI tract) results from coordinated contractions of smooth muscle, which in turn derive from ... In patients with abnormalities of stomach and/or gastrointestinal motility, the rhythm often is irregular or there is no post- ... a document prepared by the gastric section of the American Motility Society Clinical GI Motility Testing Task Force" (PDF). ...
"Theravance Biopharma: Programs , Gastrointestinal Motility Dysfunction". SITE. (Mu-opioid receptor antagonists, Pharmacology). ... They act on gut motility, gut secretion and sphincter function. PAMORAs effect on gut motility is that it can increase the ... piperidine opioid antagonists were developed for the treatment of gastrointestinal motility disorder by Zimmerman and his ... The MORs in the gastrointestinal tract are the main receptors that PAMORAs are intended to block and prevent the binding of ...
Barrett KE (2014). "Intestinal Motility". Gastrointestinal Physiology (2nd ed.). New York: Lange Medical Books/McGraw-Hill. p. ...
Chapter 7: "Esophageal Motility". ISBN 978-0-07-177401-7. Long, Richard G; Scott, Brian B, eds. (2005). Specialist Training in ... 2002). Gastrointestinal disease : an endoscopic approach. section editors Firas H. Al-Kawas (2nd ed.). Thorofare, NJ: Slack. p ... The enveloped portions form the basis for the adult gastrointestinal tract. The sac is surrounded by a network of vitelline ... Sections of this gut begin to differentiate into the organs of the gastrointestinal tract, such as the esophagus, stomach, and ...
ISBN 978-0-323-01639-1. Sarna, S.K. (2010). "Introduction". Colonic Motility: From Bench Side to Bedside. San Rafael, ... Gastrointestinal cancer may occur at any point in the gastrointestinal tract, and includes mouth cancer, tongue cancer, ... Gastrointestinal physiology Gut-on-a-chip All pages with titles beginning with Gastrointestinal All pages with titles ... The Wikibook Human Physiology has a page on the topic of: The gastrointestinal system The gastro intestinal tract in the Human ...
Motility Section French Club of Gastrointestinal Motility (GFNG) German Society of Neurogastroenterology and Motility (DGNM) ... It was hosted by the Chinese Society of Gastrointestinal Motility. The second FNM meeting took take place in San Francisco, ... The journal publishes papers from scientists worldwide working in the field of gastrointestinal motility, clinical research and ... "Neurogastroenterology and Motility". Ovid. 2012. "Texas Tech faculty publish in Neurogastroenterology & Motility Journal". ...
Eosinophils are normally present in other parts of a healthy gastrointestinal tract, these white blood cells are not normally ... Nurko S, Furuta GT (2006). "Eosinophilic esophagitis". GI Motility Online. doi:10.1038/gimo49 (inactive 31 July 2022).{{cite ... Eosinophilic inflammation is not limited to the esophagus alone, and does extend through the whole gastrointestinal tract. ... D'Alessandro A (2015). "Eosinophilic esophagitis: From pathophysiology to treatment". World Journal of Gastrointestinal ...
... is a gastrointestinal motility diagnostic system that measures intraluminal pressure activity in the gastrointestinal tract ... Bredenoord, Albert J.; Smout, André; Tack, Jan (2016). A Guide to Gastrointestinal Motility Disorders. Springer. p. 17. ISBN ...
Factors influencing gastrointestinal absorption: Gastrointestinal motility. Splanchnic blood flow. Particle size and ... Enteral administration is food or drug administration via the human gastrointestinal tract. This contrasts with parenteral ... Enteral administration involves the esophagus, stomach, and small and large intestines (i.e., the gastrointestinal tract). ...
"Handbook of gastrointestinal motility and functional disorders". Dr. Rao penned the book "G.I. Motility Testing: A laboratory ... Rao has edited ten books including Gastrointestinal Motility: tests and problem-oriented approach, " ... Rao has edited 10 books, including Handbook of GI Motility (2015), and Clinical and Basic Neurogastroenterology & Motility ( ... Handbook of gastrointestinal motility and functional disorders. ISBN 978-1-63091-203-1. OCLC 910845666. "Satish Rao - Google ...
Fujimiya, Mineko; Inui, Akio (2000). "Peptidergic regulation of gastrointestinal motility in rodents". Peptides. Elsevier BV. ... In the gastrointestinal tract, mucosal mast cells are located in close proximity to sensory nerve fibres, which communicate ... Lee J, Veatch SL, Baird B, Holowka D (2012). "Molecular mechanisms of spontaneous and directed mast cell motility". J. Leukoc. ... Functional gastrointestinal disorders (FGIDs) are characterized by chronic complaints arising from disorganized brain-gut ...
Problems with motility may either be diffuse, or localized to particular areas. MMC impairment may be a result of post- ... Rolfe RD (February 2000). "The role of probiotic cultures in the control of gastrointestinal health". The Journal of Nutrition ... Absence or impairment of the migrating motor complex (MMC), a cyclical motility pattern in the small intestine, and phase III ... These factors can be grouped into four categories: (1) disordered motility or movement of the small bowel or anatomical changes ...
ISBN 978-0-89043-840-4. Jones, Kenneth R.; Heymen, Steve (1988). "Using Relaxation: Coping with Functional Gastrointestinal ... Disorders" (PDF). UNC Center for Functional GI & Motility Disorders. Archived from the original (PDF) on 2019-03-03. Different ...
... the drug is indicated in upper gastrointestinal motility disorders and to prevent gastrointestinal symptoms associated with the ... However, it is available in the United States for people with severe and treatment-refractory gastrointestinal motility ... Jost WH (April 1997). "Gastrointestinal motility problems in patients with Parkinson's disease. Effects of antiparkinsonian ... Poor gastrointestinal function, nausea and vomiting is a major problem for people with Parkinson's disease because most ...
They serve a pacemaker function in controlling motility. Most GISTs are sporadic. Less than 5% occur as part of hereditary ... Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. GISTs arise in ... many non-epithelial tumors of the gastrointestinal tract were called "gastrointestinal stromal tumors". Histopathologists were ... KIT-p.D419del (exon 8) - A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic ...
... new players in gastrointestinal motility?". Laboratory Investigation. 87 (7): 628-32. doi:10.1038/labinvest.3700564. PMID ...
Prokinetics may be used to improve gastrointestinal motility. A number of new agents have shown positive outcomes in chronic ... Certain calcium channel blockers such as nifedipine and verapamil can cause severe constipation due to dysfunction of motility ... Constipation is the most common chronic gastrointestinal disorder in adults. Depending on the definition employed, it occurs in ... Gyger G, Baron M (2015). "Systemic Sclerosis: Gastrointestinal Disease and Its Management". Rheum Dis Clin North Am (Review). ...
While ulimorelin has been shown to increase both upper and lower gastrointestinal motility in rats, and showed promising ... It has been researched for enhancing gastrointestinal motility, especially in gastroparesis and in aiding recovery of bowel ... Greenwood-Van Meerveld B, Kriegsman M, Nelson R (November 2011). "Ghrelin as a target for gastrointestinal motility disorders ... "Safety and efficacy of ulimorelin administered postoperatively to accelerate recovery of gastrointestinal motility following ...
"The gastrointestinal tract of the rock hyrax (Procavia habessinica). 1. Morphology and motility patterns of the tract". ...
Schuster Atlas of Gastrointestinal Motility in Health and Disease. PMPH-USA. pp. 92-. ISBN 978-1-55009-104-5. Nifedipine has ... Physiology of the Gastrointestinal Tract, Two Volume Set. Academic Press. pp. 952-. ISBN 978-0-12-382027-3. ... The barostat ...
Scleroderma can decrease motility anywhere in the gastrointestinal tract. The most common source of decreased motility is the ... Patients with severe gastrointestinal involvement can become profoundly malnourished. Scleroderma may also be associated with ... It can be a cause of upper gastrointestinal bleeding or iron-deficiency anemia in patients with scleroderma. Kidneys Kidney ... Visceral organs, including the kidneys, heart, lungs, and gastrointestinal tract can also be affected by the fibrotic process. ...
The total time necessary for the test depends on the speed of bowel motility or transit time and may vary between 1 and 3 hours ... whereas the barium enema is called a lower gastrointestinal series (or study). In upper gastrointestinal series examinations, ... An upper gastrointestinal series, also called a barium swallow, barium study, or barium meal, is a series of radiographs used ... Complete gastrointestinal obstruction is a contraindication for barium studies. Barium sulfate as a contrast medium was evolved ...
Drugs used to enhance gastrointestinal motility are generally referred to as prokinetics. Serotonin induces phase III of the ... Hasler W (2006). Physiology of the Gastrointestinal Tract (Fourth ed.). Boron WF, Boulpaep EL (2012). Medical physiology : a ... Takahashi T (July 2012). "Mechanism of interdigestive migrating motor complex". Journal of Neurogastroenterology and Motility. ... is a pattern of electrical activity observed in the gastrointestinal tract in a regular cycle during fasting. MMC was ...
Gastrointestinal issues are also very common in this patient population. Digestive motility issues may result in constipation. ...
Timmermans, J.-p.; Adriaensen, D. (2007-12-17). "Gastrointestinal mechanosensors: analysis of multiple stimuli may require ... complex sensors". Neurogastroenterology & Motility. 20 (1): 4-7. doi:10.1111/j.1365-2982.2007.01049.x. ISSN 1350-1925. Flammang ...
Study of gastrointestinal motility using an extraluminal force transducer. 6. Observation of gastric and duodenal motility ... which gives increased stimulation of myenteric neurons and gastrointestinal motility. The remainder is synthesized in ... However, since serotonin is a major gastrointestinal tract modulator, it may be produced in the fruits of plants as a way of ... Gastrointestinal and Liver Physiology. 296 (4): G963-G968. doi:10.1152/ajpgi.90709.2008. PMID 19246633. Collet C, Schiltz C, ...
July 2014). "Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility". Cell. 158 (2): ...
"Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function". Neurogastroenterology and Motility ... Neurogastroenterology and Motility. 30 (2): e13283. doi:10.1111/nmo.13283. PMID 29341448. S2CID 39904059. Bendheim PE, ... human microbiota and has only been detected in vivo when the species Clostridium sporogenes is present in the gastrointestinal ... studies demonstrate that the introduction of enteric bacteria capable of IPA production in vivo into the gastrointestinal tract ...
"Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function". Neurogastroenterology & Motility. ... "Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms?". Biomarkers. 14 (8): 596-603. doi: ...
Mediators and Drugs in Gastrointestinal Motility II: Endogenous and Exogenous Agents. Springer Science & Business Media. 6 ... Hanauer SB (Winter 2008). "The role of loperamide in gastrointestinal disorders". Reviews in Gastroenterological Disorders. 8 ( ... US patent 5612054, Jeffrey L. Garwin, "Pharmaceutical compositions for treating gastrointestinal distress", issued 1997-03-18, ...
Non-biliary causes of PCS may be caused by a functional gastrointestinal disorder, such as functional dyspepsia. Chronic ... Tricyclic antidepressants have also been proven effective for nausea, vomiting, early satiety, impaired motility and other ... Gastrointestinal Endoscopy. 68 (1): 69-74. doi:10.1016/j.gie.2007.09.046. PMID 18577477. Schmidt M, Søndenaa K, Dumot JA, ... "Post-cholecystectomy symptoms were caused by persistence of a functional gastrointestinal disorder". World Journal of ...
Following generation time in the cytoplasm of the host cells, the bacteria utilizes actin based motility to move through the ... gastrointestinal system, or kidneys. Long-term health problems following acute Rocky Mountain spotted fever infection include ...
PPY - inhibition of upper GI tract motility GLP-1 - Functions as an "Ileal Brake" to inhibit upper GI tract motility when the ... These pacemaker cells, also called the ICCs, control the frequency of contractions in the gastrointestinal tract. The cells can ... Distension of the stomach increases motility of the stomach. Distension of the duodenum inhibits stomach motility in order to ... Parasympathetic nervous system innervation stimulates gastric motility. Rate and motility are also dependent upon the meal ...
Fritsch WP, Hausamen TU, Scholten T (April 1977). "[Gastrointestinal hormones. I. Hormones of the gastrin group]". Zeitschrift ... by the parietal cells of the stomach and aids in gastric motility. It is released by G cells in the pyloric antrum of the ... Neurogastroenterology and Motility. 9 (4): 265-70. doi:10.1046/j.1365-2982.1997.d01-59.x. PMID 9430795. S2CID 31858033. ...
Kiso, T. (November 2001). "A novel 5-HT3 receptor agonist, YM-31636, increases gastrointestinal motility without increasing ... Systemic administration of YM-31636 increased the number of fecal pellets in rats, and improves colonic motility. It also ...
Bile acid malabsorption can also be secondary to cholecystectomy, vagotomy and other disorders affecting intestinal motility or ... to ensure passage of the capsule into the gastrointestinal tract. The physical half life of 75Se is approximately 118 days; ...
... and oesophageal motility disorders including the nutcracker oesophagus, achalasia, diffuse oesophageal spasm, and oesophageal ... Functional gastrointestinal disorder Gastrointestinal malformations Gastrointestinal bleeding "An overview on oral ... Gastrointestinal diseases (abbrev. GI diseases or GI illnesses) refer to diseases involving the gastrointestinal tract, namely ... "Gastrointestinal cancer" describes the specific malignant conditions of the gastrointestinal tract. In general, a significant ...
... gastrointestinal motility problems, recurrent infections, and genitourinary abnormalities. Many of those affected by M2DS also ...
Urinary retention, decreased gastrointestinal motility (paralytic ileus), hyperthermia (or hypothermia), hypertension, dilated ... Doxepin is well-absorbed from the gastrointestinal tract but between 55 and 87% undergoes first-pass metabolism in the liver, ...
The studies he conducted into neuronal reflexes that enable intestinal motility and the neurotransmitters that are involved led ... 2002). Innervation of the gastrointestinal tract: Volume 14 of Autonomic nervous system. Taylor & Francis. ISBN 9780415283779. ... Federation of Neurogastroenterology and Motility (FNM) Societies Lifetime Achievement Award in recognition of his research and ... Australian Centenary Medal and the inaugural Lifetime Achievement Award by the Federation of Neurogastroenterology and Motility ...
... several respiratory reflexes and reflexes within the gastrointestinal system regulating motility and secretion. Neurons which ... gastrointestinal system, pharynx, and liver via the glossopharyngeal and vagus nerves. Organ specific regions of neuronal ... The signals projected from the SN to the parabrachial area originate in the oral cavity and gastrointestinal tract. The ... while those receiving information from cardio-respiratory and gastrointestinal processes are found in the caudal part. Taste ...
The intestinal epithelium has a complex anatomical structure which facilitates motility and coordinated digestive, absorptive, ... Enteroendocrine cells secrete various gastrointestinal hormones including secretin, pancreozymin, enteroglucagon among others. ... of the gastrointestinal tract. Composed of simple columnar epithelial cells, it serves two main functions: absorbing useful ...
... decreased gastric motility (e.g. due to head injury) or pyloric obstruction (e.g. pyloric stenosis). Delayed gastric emptying ... full stomach and altered gastrointestinal mobility. Increased fasting times leads to decreased injury if aspiration occurs. The ...
Scopine Daturadiol Bawazeer, Saud; Rauf, Abdur; Bawazeer, Sami (2020). "Gastrointestinal Motility, Muscle Relaxation, ...
... is no research evidence that reliably corroborates the assumed association between bowel sounds and gastro-intestinal motility ...
... resulting in an increase in gastric motility and digestion; whereas pirenzepine would inhibit these actions and cause decreased ... Gastrointestinal system drug stubs). ... gastric motility leading to delayed gastric emptying and ...
It reduces gastric motility and secretion and is used for the treatment of peptic ulcer and dyspepsia. Martindale W (1967). " ... Gastrointestinal system drug stubs). ...
Umpierre, S. A; Hill, J. A; Anderson, D. J (1985). "Effect of Coke on Sperm Motility". New England Journal of Medicine. 313 (21 ... Gastrointestinal Endoscopy. 63 (1): 119-120. doi:10.1016/j.gie.2005.10.014. PMID 16377328. Blackler, Alethea L.; Gomez, Rafael ...
Hydrocodone decreases gastrointestinal (GI) motility by increasing smooth muscle tone and decreasing propulsive contractions, ... known or suspected gastrointestinal obstructions (including paralytic ileus). It is also contraindicated in patients that have ...
With TPN, there is a reduction in gastrointestinal motility, immunity, with an increase in permeability. These changes ... Total parenteral nutrition (TPN) is given to patients with intestinal failure or a variety of other gastrointestinal problems. ... World Journal of Gastrointestinal Endoscopy. 10 (8): 130-144. doi:10.4253/wjge.v10.i8.130. PMC 6107471. PMID 30147845. Parikh ...
Anticholinergic drugs reduce gastric motility, prolonging the time drugs spend in the gastrointestinal tract. This impairment ... Gastrointestinal upset can cause severe discomfort; it is most common when metformin is first administered, or when the dose is ... The most common adverse effect of metformin is gastrointestinal irritation, including diarrhea, cramps, nausea, vomiting, and ... McCreight LJ, Bailey CJ, Pearson ER (March 2016). "Metformin and the gastrointestinal tract". Diabetologia. 59 (3): 426-35. doi ...
These GTPases regulate cell motility, proliferation and also contribute to tumor progression and invasion. In many cell types, ... gastrointestinal stromal tumors, glioblastoma, and neuroblastoma. Nedd9 expression may be important for recovery from stroke. ... NEDD9 stabilizes formation and regulates turnover of focal adhesions, influencing cell motility and the invasion and metastasis ... motility and homing into marginal zones of spleen Estrogen Receptor. The NEDD9 interactors p130/CAS and the NSP protein NSP2/ ...
Motility stimulants, Muscarinic antagonists, Peripherally selective drugs, Phenothiazines, Piperidines, All stub articles, ... Gastrointestinal system drug stubs). ...
Kho DH, Nangia-Makker P, Balan V, Hogan V, Tait L, Wang Y, Raz A (February 2013). "Autocrine motility factor promotes HER2 ... Elevated serum GPI levels have been used as a prognostic biomarker for colorectal, breast, lung, kidney, gastrointestinal, and ... The encoded protein is also referred to as autocrine motility factor (AMF) based on an additional function as a tumor-secreted ... Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK, Chiang PK, Schiffmann E (May 1986). "Tumor cell autocrine motility factor ...
His early research focussed on gastric acid output, large bowel motility and the pathophysiology of the anal sphincter. As ... joining the academic departmental programme of research into gastrointestinal physiology, studying in particular gastric acid ... Here he continued to develop research into surgery for peptic ulcer disease, large bowel motility, internal and external anal ... secretion and large bowel motility. He was appointed senior lecturer then reader in surgery at the University of Leeds with ...
... are motility stimulants that work through activation of 5-HT4 receptors of the enteric nervous system in the gastrointestinal ... It causes the intestines to produce a chloride-rich fluid secretion that softens the stool, increases motility, and promotes ... Magnesium-containing agents also cause the release of cholecystokinin, which increases intestinal motility and fluid secretion ... making it easier for them to move through the gastrointestinal tract. Properties Site of action: small and large intestines ...
The patient ingests the capsule and while it transits through the gastrointestinal system, it sends signals to the outside, ... stomach and duodenum intestinal motility intraluminal pressure Other Modern capsules, called video pills or endoscopic capsules ... The system is normally used for research purposes or for diagnosing long term changes in gastrointestinal physiological ...
Using a transposon-based genetic screen, researchers found that disruption of the PTPRK gene in gastrointestinal tract ... "Galectin-3 binding protein promotes cell motility in colon cancer by stimulating the shedding of protein tyrosine phosphatase ...
This results in further vasodilation, pupil constriction, an increase in GI tract motility and secretions, and glycogen ... 206-. ISBN 978-0-08-054111-2. Timothy S. Gaginella; James J. Galligan (25 July 1995). Serotonin and Gastrointestinal Function. ...
Research on gastrointestinal motility and functional gastrointestinal disorders. ... Research on gastrointestinal motility and functional gastrointestinal disorders. The Motility and Functional Gastrointestinal ... Gastrointestinal Motility * Terez Shea-Donohue, Ph.D. Basic and Translational Neurogastroenterology, Gastrointestinal Motility ... and the effect of gastrointestinal diseases and disorders on gastrointestinal motility. The program also supports clinical ...
The Orlando Health Digestive Health Institute Gastrointestinal Motility Center offers a multidisciplinary approach to the ... Our team includes a gastrointestinal motility specialist, thoracic and colorectal surgeons, urogynecologists, advanced ... Our specialists are here to help you through every phase of care for your motility disorder. ...
"Gastrointestinal Motility" by people in this website by year, and whether "Gastrointestinal Motility" was a major or minor ... "Gastrointestinal Motility" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical ... Below are MeSH descriptors whose meaning is related to "Gastrointestinal Motility".. *Digestive System Physiological Phenomena ... Below are the most recent publications written about "Gastrointestinal Motility" by people in Profiles. ...
Ageing and the Rate of Gastrointestinal (GIT) Motility of Malayan Box Turtles (Coura amboinensis) ... The rate of motility of GIT: the fastest rate was 22 hrs and the slowest was more than 91 hrs. ... The rate of motility of GIT in MBTs is very slow which can take up to 91 hours. There are various of routes of administration ... Estimation of the rate of motility of GIT was determined by radiograph using barium sulphate as a contrast medium. All turtles ...
The Motility Clinic consists of physicians who have special training and interests in disorders of gastrointestinal motility. ... The Motility Clinic interacts with surgeons from the Division of Colorectal Surgery who have special interest in intractable ... Gastrointestinal transit. Using noninvasive methods, it is possible to measure by scintigraphy or radiopaque marker techniques ... An irritable bowel syndrome class (supervised by the Motility Clinic) taught by a nurse who has special training in the area ...
There are two more studies that due to different estimation of intestinal motility-using the motility index48,56-are not ... Recent data48 has challenged the perception that methane and slowed intestinal motility just coexist or that the abundance of ... Certain gastrointestinal diseases have been associated with positive methane producer status, including colon cancer. As early ... The consistency of the motility findings in response to methane in the animal models and in human subjects provided for the ...
Motility disorders and functional gastrointestinal disorders (FGID) are the most common GI disorders among children. Even so, ... Symptoms of motility disorders and FGIDs can range from mild to severe. Well work together to make a plan that brings relief ... Its a privilege to be a resource for children and families facing the most severe, chronic forms of motility disorders and ...
Chapter 13, "Gastrointestinal Disease". de Bortoli, N., Martinucci, I., Bellini, M., Savarino, E., Savarino, V., Blandizzi, C ... Review this weeks media presentation on the gastrointestinal system.. Review Chapter 35 in the Huether and McCance text. ...
... are expressed in the gallbladder and gastrointestinal tract. Both regulate gastrointestinal motility. The gallstone risk allele ... Genome-wide analysis identifies gallstone-susceptibility loci including genes regulating gastrointestinal motility.. Fairfield ... and gastrointestinal motility. Anoctamin 1 (ANO1) and transmembrane Protein 147 (TMEM147), both in novel, replicated loci, ... Motilidade Gastrointestinal Predisposição Genética para Doença/genética Humanos Polimorfismo de Nucleotídeo Único População ...
The Suzi and Scott Lustgarten Center for GI Motility offers technical services for patients with GI and motility disorders. ... Surgery of gastrointestinal motility disorders. The Suzi and Scott Lustgarten Center for GI Motility works with surgeons who ... The Suzi and Scott Lustgarten Center for GI Motility offers technical services for patients with GI and motility disorders. ... Endoscopic therapies for motility disorders, POEM, EUS. Peroral endoscopic myotomy (POEM) is the most advanced endoscopic ...
In this study, the gastrointestinal transit conditions in male landrace pigs were studied with a telemetric motility capsule ... Overall, the study provides new insights of gastrointestinal conditions in landrace pigs, which can lead to more accurate ... Gastrointestinal transit ,. Intestine motility ,. Intestine transit time ,. Landrace pig; male ,. Product development ,. ... Characterization of gastrointestinal transit and luminal conditions in pigs using a telemetric motility capsule. ...
Gastrointestinal: Decreased motility or constipation. Nutritional and Gross Metabolic: Body temperature increase. VHTODE 42,354 ... Gastrointestinal: Nausea or vomiting. VCVPS* -,60,1998. Other Multiple Dose Data and References. Route/Organism. Dose. Effect. ... Gastrointestinal: Nausea or vomiting. VCVPS* -,60,1998. oral/human lowest published toxic concentration: 5.7 mg/kg. VCVPS* -,60 ... Gastrointestinal: Gastritis. Endocrine: Androgenic. TOXRE* 2,175,2015. skin/rabbit lowest published toxic dose: 24000 mg/kg/28D ...
Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society 2015 December ... Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motility disorders.. G ... motility and are used to treat acute colonic pseudoobstruction. However, their effects on gastroduodenal motility in humans are ... Our hypotheses were that, in patients with suspected GI motility disorders, neostigmine increases gastric and small intestinal ...
Gastrointestinal Motility / drug effects* * Gastrointestinal Tract / drug effects * Gastrointestinal Tract / physiopathology * ... The effects of methane and hydrogen gases produced by enteric bacteria on ileal motility and colonic transit time ... we set out to investigate whether intestinal gases including methane and hydrogen could influence the small bowel motility and ...
It also enhances gastrointestinal motility and accelerates gastric emptying time. This agent is of low cost and is generally ... AC may be helpful more than 4 hours post-ingestion, if co-ingestion with an agent that slows gut motility occurred or if a ... Gastrointestinal (GI) decontamination with oral AC is selectively used in the emergency treatment of poisoning caused by some ... Antiemetics that do not decrease gastric motility or significantly alter mental status are the drugs of choice; anticholinergic ...
... encompasses defects occurring during the digestion and absorption of food nutrients by and infections of the gastrointestinal ... Husebye E. Gastrointestinal motility disorders and bacterial overgrowth. J Intern Med. 1995 Apr. 237(4):419-27. [QxMD MEDLINE ... Camilleri M. Gastrointestinal problems in diabetes. Endocrinol Metab Clin North Am. 1996 Jun. 25(2):361-78. [QxMD MEDLINE Link] ... Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am. 1998 Sep. 27(3):563-94. [QxMD MEDLINE Link]. ...
When stimulation of gastrointestinal motility might be dangerous (e.g., in the presence of gastrointestinal hemorrhage, ... Increased gastrointestinal (GI) motility by metoclopramide may impact absorption of other drugs leading to decreased or ... When stimulation of gastrointestinal motility might be dangerous ( 4) *Pheochromocytoma, catecholamine-releasing paragangliomas ... Metoclopramide stimulates motility of the upper gastrointestinal tract without stimulating gastric, biliary, or pancreatic ...
Camilleri M. Disorders of gastrointestinal motility. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. ... Sleisenger and Fordtrans Gastrointestinal and Liver Disease. 11th ed. Philadelphia, PA: Elsevier; 2021:chap 19. ...
These agents decrease gastrointestinal motility, which may delay the excretion of infective gastroenteric organisms and/or ... or recent gastrointestinal tract surgery. Gastrointestinal effects appear to be the most pronounced with morphine. ... impaired GI motility. Major Potential Hazard, High plausibility. Applicable conditions: Inflammatory Bowel Disease, ... In patients with severe or acute inflammatory bowel disease, the decrease in colonic motility may induce toxic megacolon. ...
Smooth muscle, calcium signaling, gastrointestinal motility. Seungil Ro. [email protected]. Gastrointestinal disease, diabetes, ...
Asyia S. Ahmad, MD: Gastroenterology, Sp: Gastrointestinal motility disorders, esophageal disorders, digestive disorders in ... Arturo Loaiza-Bonilla, MD: Medical Oncology, Sp: Gastrointestinal cancer, colon and rectal cancer, esophageal and gastric ... L. Grier Arthur III, MD: Pediatric Surgery, Sp: Minimally invasive surgery, gastrointestinal surgery, neonatal Surgery, biliary ...
gastrointestinal endocrinology. *gastrointestinal motility. *gastrointestinal regulatory peptides. *gastrointestinal hormones. ... 1Gastrointestinal Sciences, University of Manchester, Hope Hospital, Salford, UK. *. 2Neuroscience and Psychiatry Unit, ... Correspondence to Professor David G Thompson, Gastrointestinal Sciences, Clinical Sciences Building, Manchester Academic Health ...
He developed the Gastrointestinal Motility Laboratory at Riley Hospital, one of the few comprehensive centers in the United ... Croffies clinical and research expertise is in pediatric gastrointestinal motility (movement) disorders and biofeedback ... Croffies research expertise is in pediatric gastrointestinal motility (movement) disorders and biofeedback treatment of ... International Foundation for Functional Gastrointestinal Disorders North American Society for Pediatric Gastroenterology, ...
Heart rate, blood pressure, gastrointestinal motility, galvanic skin response, and biochemical indicators were measured as ... Subjective ratings of sounds correlated with gastrointestinal motility changes; the relationship was greater for nonaversive ... only gastrointestinal motility changes provided some stimuli differentiation. ...
Active gastrointestinal inflammatory, gastrointestinal motility disorders, and chronic gastritis, such as ulcerative colitis, ... chronic or concurrent use of gastrointestinal motility modulators (domperidone, loperamide, erythromycin metoclopramide etc.); ... Any conditions or factors that, in the judgment of the Investigator, somehow may impact gastrointestinal absorption. ...
Standards for diagnosis of gastrointestinal motility disorders. Section: ultrasonography. A position statement from the Gruppo ... Gall-bladder motility could be the clue for symptomatic or asymptomatic gallstones, as sluggish gall-bladder motility could ... Impaired gall bladder motility was evident in patients with beta-thalassaemia and it may be related to disease duration, serum ... Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in β- ...
  • Research on gastrointestinal motility and functional gastrointestinal disorders. (
  • and the effect of gastrointestinal diseases and disorders on gastrointestinal motility. (
  • The program also supports clinical trials to test new treatments for functional gastrointestinal disorders and epidemiology studies to address risk factors for disease occurrence, prognosis, or natural history. (
  • Specialized care for motility disorders. (
  • The Orlando Health Digestive Health Institute Gastrointestinal Motility Center offers a multidisciplinary approach to the disorders affecting your body's ability to move food and nutrition through your stomach, intestines and other organs. (
  • Nurko S. Motility Disorders in Children. (
  • The Motility Clinic consists of physicians who have special training and interests in disorders of gastrointestinal motility. (
  • However, we have not identified yet the mechanism of action of methane on intestinal motility, and since methane production does not account for all constipation associated cases, there is need for high quality clinical trials to examine methane as a biomarker for the diagnosis or as a biomarker that predicts antibiotic treatment response in patients with constipation related disorders. (
  • 4 However, recently, methane has been associated with gastrointestinal disorders, mainly chronic constipation and constipation predominant irritable bowel syndrome (IBS), 4 , 5 as well as metabolic diseases like obesity. (
  • Motility disorders and functional gastrointestinal disorders (FGID) are the most common GI disorders among children. (
  • It's a privilege to be a resource for children and families facing the most severe, chronic forms of motility disorders and FGIDs. (
  • Symptoms of motility disorders and FGIDs can range from mild to severe. (
  • The Suzi and Scott Lustgarten Center for GI Motility offers technical services for patients with GI and motility disorders. (
  • Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motility disorders. (
  • Our hypotheses were that, in patients with suspected GI motility disorders, neostigmine increases gastric and small intestinal motor activity, and these effects are greater in patients with cardiovagal neuropathy, reflecting denervation sensitivity. (
  • Camilleri M. Disorders of gastrointestinal motility. (
  • Dr. Croffie's clinical and research expertise is in pediatric gastrointestinal motility (movement) disorders and biofeedback treatment of constipation. (
  • Areas of Interest: GI motility disorders, anorectal manometry, gastroduodenal manometry, colonic manometry, high resolution esophageal and anorectal manometry, esophageal pH and impedence studies, biofeedback treatment for severe childhood constipation, fecal transplant for recurrent Clostridium Difficil e infection. (
  • These simple tests give an overview of the functions of the entire gastrointestinal tract. (
  • The composition of gases generated in the intestine shows both inter-individual variability and variability among the different anatomical sites of the gastrointestinal tract. (
  • Anoctamin 1 (ANO1) and transmembrane Protein 147 (TMEM147), both in novel, replicated loci, are expressed in the gallbladder and gastrointestinal tract . (
  • Narcotic (opioid) analgesic agents increase smooth muscle tone in the gastrointestinal tract and decrease peristalsis, which can lead to elevated intraluminal pressure, spasm, and constipation following prolonged use. (
  • Therapy with opioids should be administered cautiously in patients with gastrointestinal obstruction, constipation, inflammatory bowel disease, or recent gastrointestinal tract surgery. (
  • It encompasses defects that occur during the digestion and absorption of food nutrients by, and infections of, the gastrointestinal tract. (
  • Models of Gastrointestinal Tract Motility. (
  • Most bacterial nosocomial pneumonias occur by aspiration of bacteria colonizing the oropharynx or upper gastrointestinal tract of the patient. (
  • This refers to the contraction of the smooth muscles in the gastrointestinal tract. (
  • Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome. (
  • Gastrointestinal and liver physiology 2008 Jan 294 (1): G13-9. (
  • When I was a fellow and trainee at Northwestern University, some of the best research focused on gastrointestinal motility and physiology. (
  • The Motility Clinic interacts with surgeons from the Division of Colorectal Surgery who have special interest in intractable constipation and fecal incontinence. (
  • In patients with severe or acute inflammatory bowel disease, the decrease in colonic motility may induce toxic megacolon. (
  • However, their effects on gastroduodenal motility in humans are poorly understood. (
  • In this open label study, the effects of neostigmine (1 mg intravenously) on gastroduodenal motor activity recorded with manometry were assessed in 28 patients with a suspected GI motility disorder. (
  • Thorn SE, Wattwil M, Kallander A "Effects of epidural morphine and epidural bupivacaine on gastroduodenal motility during the fasted state and after food intake. (
  • Therefore, we set out to investigate whether intestinal gases including methane and hydrogen could influence the small bowel motility and colonic transit. (
  • Enteric glial cells: new players in gastrointestinal motility? (
  • He developed the Gastrointestinal Motility Laboratory at Riley Hospital, one of the few comprehensive centers in the United States providing esophageal manometry, anorectal manometry and anorectal biofeedback therapy, small bowel and colonic manometry, wireless esophageal pH testing, and esophageal pH and impedance testing to children with various gastrointestinal motor disorders. (
  • Bowel motility is one of the most complex and sophisticated functions in the human body. (
  • Serotonin also has implications that affect gastrointestinal processes like bowel motility, bladder control, and cardiovascular function. (
  • Pathway enrichment revealed associations with lipid homeostasis , glucuronidation, phospholipid metabolism , and gastrointestinal motility . (
  • Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation. (
  • Our specialists are here to help you through every phase of care for your motility disorder. (
  • Gastrointestinal Motility" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (
  • Impaired gall bladder motility was evident in patients with beta-thalassaemia and it may be related to disease duration, serum ferritin and total serum bilirubin level. (
  • METHODS: From November 2017, an upper gastrointestinal endoscopy (UGE) was proposed at least 3 years after SG to all patients operated on in our institution. (
  • Exclusion criteria were patients ity could protect the patient from pain [ 6 ], suffering from obesity, diabetes or liver while preserved gall-bladder motility in cirrhosis. (
  • In this study, the gastrointestinal transit conditions in male landrace pigs were studied with a telemetric motility capsule under fasted and postprandial conditions. (
  • These agents decrease gastrointestinal motility, which may delay the excretion of infective gastroenteric organisms and/or their toxins. (
  • Comment: Coadministration of anticholinergic drugs and glucagon increase the risk of gastrointestinal adverse reactions due to additive effects on inhibition of gastrointestinal motility. (
  • General principles of gastrointestinal function - motility, nervous control, and blood circulation. (
  • Doctors often perform pH monitoring and impedance testing along with gastrointestinal endoscopy. (
  • Acetylcholinesterase inhibitors (ACIs), e.g., neostigmine, are known to increase upper and lower gastrointestinal (GI) motility and are used to treat acute colonic pseudoobstruction. (
  • Gall-bladder motility could be ees for blood transfusion, chelation therapy the clue for symptomatic or asymptomatic by subcutaneous desferrioxamine and fol- gallstones, as sluggish gall-bladder motil- low up. (
  • Overall, the study provides new insights of gastrointestinal conditions in landrace pigs, which can lead to more accurate interpretation of in vivo results obtained of pharmacokinetic studies in preclinical models. (
  • Heart rate, blood pressure, gastrointestinal motility, galvanic skin response, and biochemical indicators were measured as physiological responses, and affective and semantic rating scales were used as subjective responses. (
  • Gastrointestinal effects appear to be the most pronounced with morphine. (
  • Nitrate in the diet may even enhance host defenses against gastrointestinal pathogens by modulating platelet activity, and possibly even gastrointestinal motility and microcirculation [McKnight et al. (
  • This graph shows the total number of publications written about "Gastrointestinal Motility" by people in this website by year, and whether "Gastrointestinal Motility" was a major or minor topic of these publications. (
  • This procedure is done during gastrointestinal endoscopy for some children or teens with gastroparesis. (
  • Gastrointestinal (GI) decontamination with oral AC is selectively used in the emergency treatment of poisoning caused by some drugs and chemicals. (
  • The rate of motility of GIT in MBTs is very slow which can take up to 91 hours. (